Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

0.95
Delayed Data
As of Jun 27
 +0.02 / +2.15%
Today’s Change
0.46
Today|||52-Week Range
4.10
-21.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues4.0M6.7M6.0M2.9M
 
 
 
 
 
Depreciation And Amortization70.0K62.0K66.0K56.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses9.5M11.4M9.4M6.9M
 
 
 
 
 
Research And Development6.5M8.3M6.6M4.6M
 
 
 
 
 
Total Operating Expenses9.6M11.4M9.5M6.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.6M-4.7M-3.5M-4.0M
 
 
 
 
 
Extraordinary Credit0.00131.0K0.00667.0K
 
 
 
Extraordinary Charge-429.0K0.000.00-431.0K
 
 
 
Other Expenses-7.0K-14.0K1.7M10.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.0M-4.6M-1.7M-3.7M
 
 
 
 
 
Net Income-6.0M-4.6M-1.7M-3.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.5M28.5M29.8M29.8M
 
 
 
 
 
Shares To Calculate EPS Diluted23.5M28.5M29.8M29.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.26-$0.16-$0.06-$0.12
 
 
 
 
 
EPS Diluted-$0.26-$0.16-$0.06-$0.12